TMFLilDebbie

Shannon Jones

General Information

Name:
Shannon Jones
Fool Since:
August 18 2015
Aliases:
TMFMPius (3/3/2017), TMFLittleDebbie (3/3/2017)
Where I Live:
Alexandria, VA

Investing Basics

Investing Experience:
Medium High
Risk Tolerance:
Medium High
Investing Style:
Motley (i.e. Anything goes!)
Portfolio Size:
Large (12 or more Stocks)
Types of Investments:
Love small/mid-cap companies with a high potential for growth. Particular interest in biopharma but balanced with a sprinkling of tech and financial positions.
Stocks I Own:
AAPL, NBIX, ONCE, BLCM, AIEQ, BRK.B, AMZN, JNJ, V, SQ, MRK, MJ, DIS

Investing Favorites

Industries:
Biopharma, financials/fintech, tech, cannabis
Books:
Financial Shenanigans by H. Schilit, The Little Book of Valuation, Inside The FDA, The Intelligent Investor
Newsletters:
Rule Breakers, Supernova
People:
Aswath Damodaran, David Gardner, Tom Gardner,

Education And Work Information

School(s) Attended
East Carolina University - B.S. Neuroscience, Northeastern University - M.S. Regulatory Affairs for Drugs, Biologics, and Medical Devices, Northeastern University - M.S. in Finance
Former Jobs
Recovering Biotech Employee and Federal Government Worker

Interests

Favorite Vacation Spots:
Charleston, SC & Hawaii
Favorite Sports or Teams:
Carolina Panthers (#Keep Pounding!)

TMFLilDebbie is following 1 Fool

My Story

I've had always had a passion for science. The complexities of the human body absolutely fascinate me. After studying neuroscience in college, I went to work for a biotech company and it was there that I fell in love with the intersection of science and business. I love analyzing biopharma strategy...everything from the early phases of clinical development to commercialization. Biotech keeps you humble, both as an investor and as a science enthusiast. New developments happen everyday in this field. As a result, my own personal Motley is... "Never Graduate!"

How I Invest

As once spoken by a respected biotech CEO...."Look for good, sound science first...the rest will follow." My investing has evolved though. Sound science is a crucial first step. Looking for companies with sound science AND sound commercial viability are keys to winning the long game in biopharma.